Although the role of CCL5/CCR5 axis in carcinogenesis is controversial [46], increasing evidence has demonstrated that constitutive CCL5 expression enables tumor immune recognition and enhances immunotherapy response via increased infiltration of CD8+ T cells into tumors [47–50]. The gene discussed is CCR5; the disease is neoplasm.